Pharmacological properties of a potential tranquilising agent mesylphenacyrazine. I. Interaction with drugs influencing the nervous system.
D000661:Amphetamine / Q000037:antagonists & inhibitors*; D000818:Animals; D001921:Brain / Q000187:drug effects; D002110:Caffeine / Q000037:antagonists & inhibitors*; D004357:Drug Synergism; D004873:Ergolines / Q000037:antagonists & inhibitors*; D006634:Histamine H1 Antagonists; D051379:Mice; D010276:Parasympatholytics; D010546:Perphenazine / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology; D051381:Rats; D013331:Strychnine / Q000037:antagonists & inhibitors*; D013565:Sympatholytics; D013874:Thiopental / Q000494:pharmacology; D014149:Tranquilizing Agents / Q000494:pharmacology*; D014508:Urea / Q000031:analogs & derivatives / Q000037:antagonists & inhibitors
D004873:Ergolines; D006634:Histamine H1 Antagonists; D010276:Parasympatholytics; D010879:Piperazines; D013565:Sympatholytics; D014149:Tranquilizing Agents; D002110:Caffeine; D014508:Urea; D000661:Amphetamine; D010546:Perphenazine; D013331:Strychnine; D013874:Thiopental